newsfilter
← Latest News
GlobeNewswire·

Brickell Biotech Announces Closing of $8.05 Million Bought Deal Offering of Common Stock, Including Full Exercise of the Underwriter's Option to Purchase Additional Shares

BOULDER, Colo., July 22, 2021 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (NASDAQ:BBI) (the "Company" or "Brickell"), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment